Anti-Ro/SSA autoantibody-positive women's experience of information given on the risk of congenital heart block.

about

Anti-Ro/SSA autoantibody-positive women's experience of information given on the risk of congenital heart block.

Item

http://www.wikidata.org/entity/Q40209354

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Anti-Ro/SSA autoantibody-posit ...... isk of congenital heart block.

@en

type

Item

label

Anti-Ro/SSA autoantibody-posit ...... isk of congenital heart block.

@en

prefLabel

Anti-Ro/SSA autoantibody-posit ...... isk of congenital heart block.

@en

P1476

Anti-Ro/SSA autoantibody-posit ...... risk of congenital heart block

@en

P2093

A Ambrosi

http://www.w3.org/2001/XMLSchema#string

A Hjelmstedt

http://www.w3.org/2001/XMLSchema#string

J Tingström

http://www.w3.org/2001/XMLSchema#string

S-E Sonesson

http://www.w3.org/2001/XMLSchema#string

P2860

Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.

Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.

The need for worldwide policy and action plans for rare diseases.

Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn.

Ro52 autoantibody-positive women's experience of being pregnant and giving birth to a child with congenital heart block.

A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block.

Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.

Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution.

Parental decision-making in congenital heart disease.

P304

536-542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203315620760

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marie Wahren-Herlenius

E Welin-Henriksson

P577

2015-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26670329

http://www.w3.org/2001/XMLSchema#string

P921

birth defect

autoantibody